Skip to content

nterventions to enhance infection by the tuberculosis agent identification and treatment prescription in persosn without active disease.

Public health actions to enhance latent TB infection treatment.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2h9smt
Enrollment
Unknown
Registered
2015-02-24
Start date
2015-01-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Latent tuberculosis infection

Interventions

The study will consist of two phases. In the first phase, we will conduct a survey to identify the bottlenecks in the different steps since the identification of contacts to the treatment of those who
Behavioural
I02.233.332
SH1.030.030.050

Sponsors

Rio de Janeiro Secretaria Municipal de Saúde
Lead Sponsor
Centro de Pesquisas Aggeu Magalhães (CPqAM)
Collaborator
Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD)
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: In the first phase (diagnosis of the bottlenecks) Subjects with active pulmonary tuberculosis and their household contacts aged 18 or over; health care workers who assist tuberculosis patients In the second phase (intervention): Household contacts of patients with active pulmonary tuberculosis; any age; health care workers who assist tuberculosis patients

Exclusion criteria

Exclusion criteria: Only in the first phase: not agreement to participate or sign the informed consent. No associated co-morbidity prevents the participant to take part in the study (mainly concerning active tuberculosis screening).

Design outcomes

Primary

MeasureTime frame
20% increase in the proportion of subjects (among all identified contacts) that start latent tuberculosis infection treatment verified through the contact registry book

Secondary

MeasureTime frame
Increase in number of identified contacts/index-case verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome. ;Increase in the proportion of identified contacts submitted to tuberculin skin testing verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome.;Increase in the proportion of contacts submitted to tuberculin skin testing with reading verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome.;Increase in the proportion of contacts with positive tuberculin skin testing who undergo complete examination to rule out active tuberculosis verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome.;Increase in the proportion of those with a positive tuberculin skin testing and no active tuberculosis who are started on treatment verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome.;Increase in the proportion of those who complete treatment verified through the contact registry book OBS: it is not possible to foresee in which proportion each of these steps will increase. The sample size was calculated based on a 20% increase of the primary outcome.

Countries

Brazil

Contacts

Public ContactAnete Trajman

Universidade Federal do Rio de Janeiro

atrajman@gmail.com+5521-982189194

Outcome results

None listed

Source: REBEC (via WHO ICTRP)